Thirty tumors including 27 distinctive cutaneous neoplasms and 3 metastatic tumors from 26 dogs were collected from diagnostic submissions to 3 laboratories. Characteristic histopathologic features included location in the subcutis or dermis (or both); lobular, nodular, and nest-like architecture; and a component of epithelioid cells with clear cytoplasm. Additional features present in most cases included follicular dermal papilla-like structures, low mitotic index, nuclear pleomorphism, necrosis, and mineralization. Cytoplasmic periodic acid Schiff-positivity, which was abolished by pretreatment with diastase, indicated the presence of glycogen in all cases. The oil red O stain did not demonstrate cytoplasmic lipid. Melanin granules, accentuated by the Fontana-Masson method, were observed infrequently. A sparsely cellular mucinous stroma and stromal cartilaginous differentiation were uncommon. By immunohistochemistry, neoplastic cells stained positively for cytokeratin (29 of 29), vimentin (28 of 28), S-100 protein (24 of 29), and melan A (8 of 12); results were negative for smooth muscle actin and calponin in all cases. Clinical follow-up information was obtained on all 26 dogs. One tumor recurred, 1 metastasized to a regional lymph node, and 1 metastasized to regional lymph nodes twice. In another case, possible pulmonary metastasis was noted radiographically. The findings are consistent with a poorly differentiated, low-grade, adnexal carcinoma of the skin. Similar canine cutaneous neoplasms have been reported as ''clear-cell hidradenocarcinoma'' and ''follicular stem cell carcinoma.'' The authors propose the designation ''cutaneous clear cell adnexal carcinoma.''
Introduction
Reported canine cutaneous neoplasms in which clear or vacuolated cytoplasm is a prominent feature include clear cell basal cell carcinoma, sebaceous adenoma and carcinoma, lipoma, liposarcoma, balloon cell melanocytoma and malignant melanoma, tricholemmoma (bulb or inferior type), eccrine adenoma and carcinoma, 4, 20 clear-cell hidradenocarcinoma, 8 and the recently described ''follicular stem cell carcinoma.'' 10 Most of these tumors have characteristic histologic features that make diagnosis straightforward. However, differentiation of sebaceous carcinoma, balloon cell melanoma, and follicular stem cell carcinoma may be difficult. 10 As has been noted, the follicular stem cell carcinoma and the clear-cell hidradenocarcinoma appear to be the same neoplasm. 11 The authors have investigated a series of cases of a distinctive canine cutaneous neoplasm that appears to be identical to the previously reported clear-cell hidradenocarcinoma and follicular stem cell carcinoma. In this study, the authors present the histopathologic, im-From the Armed Forces Institute of Pathology, Department of Veterinary Pathology, Washington, DC 20306-6000 (Schulman, Lipscomb, Atkin), and Marshfield Clinic Laboratories, Veterinary Services Division, Marshfield, WI 54449 (Schulman, Lipscomb). 1 Corresponding Author: F. Y. Schulman, 6 Aura's Way, Bow, NH 03304. munohistochemical, and clinical findings, as well as a discussion of cell of origin and nomenclature.
Materials and methods
From July of 1999 to August of 2003, canine subcutaneous and dermal neoplasms characterized by a lobular and nodular pattern, epithelial features, and clear cells were collected by the authors during their work for the Armed Forces Institute of Pathology (AFIP) and Marshfield Laboratories. At the request of the authors, neoplasms with these features submitted to the Baltimore, Maryland branch of Antech Laboratories were forwarded to the AFIP. Tissue specimens had been fixed in 10% neutral-buffered formalin, processed by conventional methods, embedded in paraffin, sectioned at 5 m, and stained with hematoxylin and eosin. In addition, selected sections were stained with periodic acid Schiff (PAS) with and without pretreatment with diastase, oil red O (on frozen sections), and the Fontana-Masson method for melanin.
Immunohistochemical staining was performed on deparaffinized sections using the avidin-biotin-peroxidase complex technique for cytokeratin (Keratin AE1/3, a,b monoclonal, protease pretreatment, 1:400), vimentin c (monoclonal, clone V9, premixed solution), S-100 protein a (polyclonal, 1:600), melan A d (high temperature unmasking technique, 1:25), calponin a (monoclonal, 1:400), and smooth muscle actin e (mono- clonal, no pretreatment, 1:1,600). Sections were also stained under identical conditions with normal rabbit or normal mouse serum to serve as negative controls. These immunohistochemical stains were incubated with either Diaminobenzidine a,c or 3-amino-9-ethylcarbazol f chromogen and counterstained with Mayer hematoxylin. Tumors were graded to reflect the proportion of cells stained. One plus indicated that one third or less of the neoplastic cells were positive. Two plus meant that one third to two thirds of the cells stained, and three plus was used to denote staining of two thirds to all of the tumor cells.
Clinical information was obtained from accompanying biopsy submission forms and follow-up telephone conversations with the attending clinician, veterinary technician, or owner (or all). Follow-up information was obtained on all 26 dogs. The follow-up periods ranged from 2 wk (after which 1 dog was lost to further follow up and 1 was dead) to 51 mo. The mean follow up time for the 26 cases was 19 mo and the median was 17 mo.
Results
Twenty-six primary tumors, 1 local recurrence, and 3 lymph node metastases from 26 dogs were collected. Selected histologic and immunohistochemical findings are presented in Table 1 .
Histologically, the cutaneous neoplasms ( Fig. 1 ) were lobular or nodular, supported by bands of coarse fibrous stroma, and located in the dermis (2 of 27), subcutis (10 of 27), or both (15 of 27). Frequently (19 of 27 cases), within the stroma, there were clusters of spindloid cells that recapitulated the dermal papilla of the hair follicle ( Fig. 2 ). In 6 cases, the stroma was abundant, contained collagenous matrix and mucin, and resembled the stroma surrounding normal hair follicles. Foci of stromal cartilaginous metaplasia were observed in 2 cases ( Fig. 3 ), tumors 6 and 20. The neoplastic cells were round to polygonal to spindle shaped and had a moderate to abundant amount of eosinophilic cytoplasm. A variable proportion of the neoplastic cells had clear or vacuolated cytoplasm in all cases. The cytoplasmic vacuoles had irregular margins; they were not round, sharply delimited vacuoles of the type associated with lipid. The oil red O stain did not demonstrate cytoplasmic lipid. Cytoplasmic PAS-positivity ( Fig. 4 ), which was abolished by pretreatment with diastase, indicated the presence of glycogen in all cases. Nuclei were round to oval and had finely to coarsely stippled chromatin and 1 to 4 nucleoli. Multifocally, there was palisading of nuclei along the periphery of the lobules. Marked anisocytosis and anisokaryosis were common, as were multinucleate cells with 2 to 4 generally central nuclei ( Fig. 5 ). Foci of tumor necrosis and mineral deposition were com-mon and usually occurred in the centers of lobules ( Fig. 5 ). Melanin granules, accentuated by the Fontana-Masson method, were observed infrequently ( Fig. 6 ). Most cases (16 of 27) had a low mitotic index (Յ1 per 10 40ϫ fields), but the mitotic index ranged up to 7 per 10 40ϫ fields. Growth appeared expansive, but in all cases there was sufficient nuclear atypia and pleomorphism to suggest metastatic potential. Vascular invasion was seen in 2 tumors, tumors 9b and 20. Keratinization was seen in 2 tumors, tumors 14 and 25, and contiguity with a hair follicle was seen in 2 tumors, tumors 8 and 14.
Lymph node metastases ( Fig. 7) were histomorphologically similar to the primary tumors but did not have follicular papillae, mucinous stroma, or cartilaginous metaplasia and tended to have higher mitotic indices.
By immunohistochemistry, variable numbers of neoplastic cells stained positively for cytokeratin (29 of 29) ( Fig. 8 ), vimentin (28 of 28) ( Fig. 9 ), S-100 protein (24 of 29) ( Fig. 10 ), and melan A (8 of 12) ( Fig. 11 ); tumor cells were negative for smooth muscle actin (28 of 28) and calponin (28 of 28).
The clinical and follow-up information is summarized in Table 2 . There were 4 Labrador retrievers, a Labrador retriever cross, 3 Siberian huskies, 6 mixed breed dogs, and 1 each of following breeds: Afghan Hound, Spitz, Shetland Sheepdog, German Shepherd, Malamute, Boston Terrier, Rottweiler, Dachshund, Cocker Spaniel, Springer Spaniel, Beagle, and Bassett Hound. There were 11 spayed females, 5 females, 5 males, and 5 castrated males. The ages at initial presentation ranged from 2 to 12 years; the mean age was 6.9 years and the median was 7 years. Eight primary tumors were located on the legs, 5 in the shoulder area, 3 on the neck, 3 on the hip, 2 on the flank, 2 on the thorax, and 1 each on the chin, tail, and umbilical area. Half were on the legs and shoulders.
Surgical excision was the only treatment in all cases. There was no recurrence or evidence of metastasis in 22 dogs (85%). One tumor on the neck (case no. 9) recurred after 22 months and was reexcised. This tumor recurred again and the dog was euthanized 29 months after the initial tumor was removed. Metastatic disease was not detected, but a postmortem examination was not performed. In case no. 21, a tumor from the shoulder metastasized to a regional lymph node, but the dog was free of recurrence or evidence of metastasis 17 months after removal of the lymph node. In case no. 26, a tumor from the umbilical area metastasized to inguinal lymph nodes twice; the dog was dead of unknown cause 16 months after the initial tumor and first metastasis were diagnosed and 6 months after the second lymph node metastasis was removed. In case no. 20, the dog had possible pulmonary me-tastases radiographically at the time of diagnosis and was dead 1 month later. No postmortem examination was performed.
Discussion
This tumor has not been reported in humans or in animals other than dogs. Although the tumor of this report is similar to clear cell hidradenoma and hidradenocarcinoma in humans, the latter 2 tumors generally have a characteristic hyalinized stroma, gland formation, or duct formation (or all). 12 The neoplasm described in this study appears to be identical to the canine neoplasm initially described in 1978 as clear-cell hidradenocarcinoma 8 and recently reported as follicular stem cell carcinoma. 10 The authors of the earlier study 8 based their diagnosis in large measure on their interpretation of glandular structures in 1 of the 4 neoplasms they described. In the more recent investigation, 10 evidence of follicular and apocrine differentiation was noted in 22 of 30 tumors. In mice, a cell capable of giving rise to hair follicles, sebaceous glands, sweat glands, and epidermis has been reported and named the ''follicular stem cell.'' 13 On the basis of their interpretation of divergent adnexal differentiation and the evidence of a follicular stem cell, the authors of the recent study proposed the designation follicular stem cell carcinoma.
Many of the findings in this study are similar to those of 1 or both of these previous reports. These include location in the dermis or subcutis (or both), lobular architecture, clear cells, follicular dermal papilla-like structures, cartilaginous differentiation, cytoplasmic glycogen, cytoplasmic melanin-like pigment, absence of smooth muscle actin immunoreactivity, immunohistochemical positivity for keratin, vimentin and melan A, and regional lymph node metastasis. These similarities leave little doubt that the same neoplasm is described in this study.
There are differences in the results of the investigations, however. In this study, most neoplasms were positive for S-100 protein by immunohistochemistry, whereas positivity for S-100a was not found previously. 10 This discrepancy likely reflects the use of different antibodies and techniques. S-100a is a designation for a clone of pan-S-100 protein and not the ''A'' antigen of S-100; it labels determinants that are common to the ␣ and ␤ chains of S100a and S100b. S-100 protein is not as specific as S-100a and likely stains a wider range of tissue types. Epidermal or follicular contiguity was noted in a third of their cases, 10 whereas in this study there were only 2 such cases (0.07%).
The investigations also differ in the interpretation of the histomorphology of the neoplasms. In this study, unequivocal differentiation toward specific cutaneous adnexal structures was not detected. Pseudoglandular structures, which appeared as intercellular clefts, were present in some cases, but true gland formation, characterized by polygonal cells arrayed around and forming a luminal structure, was not detected. Decapitation secretion, a strong indication of apocrine differentiation, was not observed. Cells with clear, glycogenfilled cytoplasm were present in all the cases in this study, and abundant cytoplasmic glycogen is characteristic of outer root sheath differentiation. 18 However, glycogen-filled cells may also occur or predominate in apocrine and other types of tumors, so this feature cannot be considered indicative of differentiation toward a specific cutaneous appendage. Conclusive evidence of follicular differentiation, such as trichilemmal or matrical keratinization, was not detected.
Cells with 1 to several central nuclei surrounded by cytoplasmic vacuoles were frequently observed. These cells were reminiscent of sebaceous differentiation, but unequivocal sebaceous differentiation as seen in sebaceous carcinoma, characterized by nuclei indented by round, sharply delimited, lipid-type cytoplasmic vacuoles, was not found and the cytoplasmic vacuoles did not stain with oil red O. Immunohistochemical positivity for S-100 protein and melan A also help rule out sebaceous carcinoma.
Two of the tumors had a component of cartilage similar to that seen in mixed tumors of mammary gland or sweat gland origin. Although cartilage formation may be associated with myoepithelial cells, it also can occur as a metaplastic change unrelated to myoepithelium. The consistent failure to detect smooth muscle actin and calponin, reliable markers of myoepithelium and myoepithelial tumors, 16 argues against myoepithelial differentiation.
Although balloon cell melanocytoma/malignant melanoma is included in the differential diagnosis because of the vacuolated cytoplasm and melanin-containing neoplastic cells, the follicular dermal papillae, nuclear palisading, absence of junctional activity, and the cytokeratin positivity help rule out a melanocytic neoplasm.
The presence of follicular dermal papilla-like structures is consistent with an inductive effect, as occurs during embryologic development of the pilosebaceous unit when the epidermal peg interacts with the adjacent dermis. 14 In dogs, follicular dermal papilla-like structures can be seen in trichoblastomas, 20 pilomatrixomas, and trichoepitheliomas. 17 In humans, such structures have been reported in trichoepitheliomas, 1 basal cell carcinomas, 6 apocrine poromas, 5 and spiradenocylindromas; 9 thus, follicular dermal papillae are not indicative of differentiation toward a specific adnexal structure, although they suggest cutaneous adnexal differentiation in a general sense.
Interestingly, in sections from 2 cases immuno- 
* SMA ϭ smooth muscle actin; FDP ϭ follicular dermal papillae; MI ϭ mitotic figures per 10 40ϫ fields; ND ϭ not done; NA ϭ not applicable; SQ ϭ subcutaneous; grading reflects proportion of tumor cells stained; FDP ϭ follicular dermal papillae. stained for melan A, positive staining of hair matrix cells immediately above the follicular papillae of normal hairs adjacent to the neoplasms was observed (Fig.  12 ). These cells contained melanin pigment, as did neoplastic cells in some of the tumors. These observations suggest differentiation toward hair matrix cells in those neoplasms that were melan A-positive and/or pigmented; however, these features were inconsistent and are not unique to hair matrix cells. The melan A immunohistochemical stain may be marking subcellular melanocytic structures phagocytized by the epithelial cells. 3 In a recent letter to the editor of Veterinary Pathology, it was recommended that these tumors be referred to as clear cell or balloon-cell sweat gland carcinomas on the basis of an unpublished study demonstrating immunohistochemical positivity for CAM5.2 in 6 of 6 tumors tested and the author's opinion that these neoplasms have a close analog in human malignant nodular hidradenoma. 19 Limited immunohistochemical studies on cytokeratin subtypes in canine skin and tumors have been reported. 2, 15, 21 To the best of the au-thors' knowledge, there is nothing in the peer-reviewed literature to support the contention that immunohistochemistry for CAM5.2 or any other keratin subtype can differentiate between canine adnexa or adnexal neoplasms in formalin-fixed tissue. Seven representative tumors from this study (tumors 4, 7, 18, 19, 20, 21b, and 25) were examined by members of the Department of Dermatopathology of the AFIP. In no case did these experts in human dermatopathology favor a diagnosis of malignant nodular hidradenoma, any variant of sweat gland tumor, or indeed any specific adnexal neoplasm. Rather, they favored adnexal carcinoma without specific adnexal differentiation (T. P. Lipscomb, personal communication).
The absence of unequivocal apocrine, sebaceous, or follicular differentiation makes classification of these neoplasms difficult. However, in aggregate, the location in the dermis and subcutis, epithelial features (including the consistent presence of cytokeratin-positive cells), glycogen-filled cells, melanin-containing cells, absence of epidermal-type differentiation, and pres- ence of follicular papillae support cutaneous adnexal differentiation.
The results of this study raise doubt as to the appropriateness of clear-cell hidradenocarcinoma and follicular stem cell carcinoma as names for this neoplasm. The absence of conclusive glandular differentiation is incompatible with hidradenocarcinoma. The justification for follicular stem cell carcinoma was the presence of divergent differentiation and the implication that divergent differentiation is indicative of origin from the follicular stem cell. Divergent differentiation was not evident in the tumors of this study. Instead, the findings of this study are consistent with a poorly differentiated adnexal neoplasm.
The authors agree that the likely cell of origin is a cutaneous epithelial stem cell. Recent research supports the concept that most skin cancers, including such common neoplasms as squamous cell carcinoma and basal cell carcinoma, arise from stem cells. 14 
The
skin is subjected to environmental insults that may induce cancer-causing mutations. Most cutaneous epithelial cells are rapidly lost through differentiation. Only long-term resident cells such as stem cells may amass a sufficient number of genetic injuries to undergo malignant transformation. Thus, it is likely that most cutaneous carcinomas arise from stem cells and might be called stem cell carcinomas. Factors believed to be responsible for determining the specific types of carcinomas that develop include RAS, p53, and ␤ catenin rather than the cell type of origin. 14 Current classification systems of epithelial skin tumors 4,7 are based on differentiation rather than cell type of origin. The authors propose a descriptive designation based on differentiation. The evidence supports the conclusion that this neoplasm is a primary, nonepidermal, poorly differentiated, adnexal carcinoma of the skin. The most distinctive and readily recognized histologic feature of this tumor is the presence of ''clear cells.'' Thus, the authors propose ''canine cutaneous clear cell adnexal carcinoma.'' Clinical follow-up information was obtained in all 26 cases. In 22 (85%), there was neither recurrence nor metastasis. One (4%) recurred locally twice. Two (8%) metastasized to regional lymph nodes. One of the dogs with metastatic disease was free of recurrence or evidence of metastasis 17 months after excision of the affected lymph node. The other with lymph node metastasis and the dog with 2 local recurrences were euthanized or dead from unknown cause 16 and 29 months after initial diagnosis, respectively. In another case, possible pulmonary metastasis was detected radiographically and the dog was euthanized; no necropsy was performed, so the nature of the pulmonary lesions could not be ascertained. The histomorphology of the tumors in the case that recurred and in the 2 that metastasized to lymph nodes was similar to those that were cured by surgical excision. However, 1 of the metastatic tumors had by far the highest mitotic rate (18 mitoses per 10 40ϫ fields) of the tumors examined. The tumor from the case with radiographic evidence of pulmonary metastasis also had a higher mitotic rate (7 mitoses per 10 40ϫ fields) and multiple lymphatic emboli. Thus, the findings of this study suggest that surgical excision is curative in the large majority of cases, but infrequent recurrence and metastasis are possible outcomes. High mitotic rate and lymphatic invasion may be predictive of metastasis.
These neoplasms usually have distinctive histologic features that allow diagnosis without special stains or immunohistochemistry. In questionable cases, the combination of compatible histology with cytokeratin and vimentin positivity often will be diagnostic. S-100 protein and melan A-positivity and the demonstration of cytoplasmic silver-positive granules by the Fontana-Masson method will be helpful in some cases. It is important that these uncommon neoplasms be recognized as primary skin tumors and not be considered metastatic to the skin. The apparent low incidence of recurrence and metastasis despite the frequency of prominent atypia and pleomorphism are important prognostic features.
